Intact Vascular Raises $38.9M in Series B VC Financing

▤ Summary

The round was led by New Enterprise Associates (NEA), with participation from Quaker Partners, H.I.G.In conjunction with the financing, NEA Partner Justin Klein, MD, JD, joined Intact’s Board of Directors.The funds will be used to accelerate the development and FDA approval of the company’s Tack Endovascular System.The Tack Endovascular System is designed to optimize the results of percutaneous balloon angioplasty in the treatment of peripheral arterial disease.The technology was pioneered by Dr. Peter Schneider, Director of the Division of Vascular Therapy at the Kaiser Foundation Hospital in Honolulu.

▦ Linked Companies